Applicant	Tradename	Generic Name	NDA	Approval Date	Type	RLD	Patent Number	Patent Expiration	Exclusivity Expiration
Sanofi Synthelabo	AVAPRO	irbesartan	020757	Sep 30, 1997	RX	No			SEP 30,2002
Sanofi Synthelabo	AVAPRO	irbesartan	020757	Sep 30, 1997	RX	No	5,270,317	MAR 20,2011
Sanofi Synthelabo	AVAPRO	irbesartan	020757	Sep 30, 1997	RX	Yes			SEP 30,2002

Export available with Ultimate Plan subscription:

This preview shows a limited data set. Complete access is available with a Subscription

Paragraph IV activity for: AVAPRO

Drugname	Dosage	Strength	RLD	Submissiondate
irbesartan	Tablets	75 mg, 150 mg and 300 mg	Avapro	5/25/2004

<- Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Follow DrugPatentWatch on Twitter

Bookmark or Share This Page ...